Literature DB >> 7664184

Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method.

C M Verduin1, C Hol, E Van Dijke, J A Faber, M Jansze, J Verhoef, H Van Dijk.   

Abstract

Recently, we showed that complement resistance is an important virulence factor of Moraxella (Branhamella) catarrhalis. Our study used a serum bactericidal assay to determine complement resistance in M. catarrhalis. Although the serum bactericidal assay is considered the "gold standard" for determining complement resistance, it is laborious and time-consuming and therefore not well suited for large-scale studies. Using a large number (n = 324) of M. catarrhalis isolates obtained from the sputa of patients with lower respiratory tract infections (n = 200) and young carriers (n = 124), we assessed the value of a simple "culture-and-spot" test as an alternative to the serum bactericidal assay. For both groups of isolates, the degree of concordance between the two tests used was very significant (P < 0.0001). The agreement between the two assays was estimated to be "excellent beyond chance" (as determined by Cohen's kappa test). The culture-and-spot assay is a valuable alternative to the serum bactericidal assay, not only for screening purposes as shown here but also for studying the mechanism of complement resistance in M. catarrhalis at the molecular level.

Entities:  

Mesh:

Year:  1995        PMID: 7664184      PMCID: PMC170161          DOI: 10.1128/cdli.2.3.365-368.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  25 in total

1.  Distribution of polysaccharide side chains of lipopolysaccharide determine resistance of Escherichia coli to the bactericidal activity of serum.

Authors:  R Porat; R Mosseri; E Kaplan; M A Johns; S Shibolet
Journal:  J Infect Dis       Date:  1992-05       Impact factor: 5.226

2.  Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera.

Authors:  L M Wetzler; K Barry; M S Blake; E C Gotschlich
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Outbreak of Moraxella catarrhalis in a respiratory unit.

Authors:  S J Richards; A P Greening; M C Enright; M G Morgan; H McKenzie
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

4.  Complement resistance in Branhamella (Moraxella) catarrhalis.

Authors:  C Hol; C M Verduin; E van Dijke; J Verhoef; H van Dijk
Journal:  Lancet       Date:  1993-05-15       Impact factor: 79.321

5.  Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces.

Authors:  R M Hamadeh; G A Jarvis; U Galili; R E Mandrell; P Zhou; J M Griffiss
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

6.  Bacterial resistance to complement killing mediated by the Ail protein of Yersinia enterocolitica.

Authors:  J B Bliska; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

7.  Iron and outer membrane proteins in the susceptibility of Neisseria meningitidis to human serum.

Authors:  M T Criado; M C del Río; C M Ferreirós; M Pintor; V Sáinz; J Carballo
Journal:  FEMS Microbiol Lett       Date:  1990-07       Impact factor: 2.742

8.  Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation.

Authors:  C M Verduin; M Jansze; C Hol; T E Mollnes; J Verhoef; H van Dijk
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  A study of the candidate virulence factors of Bacteroides fragilis.

Authors:  F Namavar; M A Verweij-Van Vught; D M Maclaren
Journal:  J Gen Microbiol       Date:  1991-06

10.  Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections.

Authors:  F M Boyle; P R Georghiou; M H Tilse; J G McCormack
Journal:  Med J Aust       Date:  1991-05-06       Impact factor: 7.738

View more
  6 in total

1.  Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.

Authors:  Franz-Josef Schmitz; Andreas Beeck; Mirella Perdikouli; Mechthild Boos; Susanne Mayer; Sybille Scheuring; Karl Köhrer; Jan Verhoef; Ad C Fluit
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Pneumococcal vaccination does not affect the genetic diversity of Moraxella catarrhalis isolates in children.

Authors:  J P Hays; K Eadie; R Veenhoven; C M Verduin; H Verbrugh; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

3.  Phage antibodies obtained by competitive selection on complement-resistant Moraxella (Branhamella) catarrhalis recognize the high-molecular-weight outer membrane protein.

Authors:  E Boel; H Bootsma; J de Kruif; M Jansze; K L Klingman; H van Dijk; T Logtenberg
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

4.  The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis.

Authors:  Thierry Wirth; Giovanna Morelli; Barica Kusecek; Alex van Belkum; Cindy van der Schee; Axel Meyer; Mark Achtman
Journal:  Genome Res       Date:  2007-09-25       Impact factor: 9.043

5.  Mucosal immunization with the Moraxella Catarrhalis porin m35 induces enhanced bacterial clearance from the lung: a possible role for opsonophagocytosis.

Authors:  Donna M Easton; Allan W Cripps; A Ruth Foxwell; Jennelle M Kyd
Journal:  Front Immunol       Date:  2011-05-16       Impact factor: 7.561

6.  Novel Moraxella catarrhalis prophages display hyperconserved non-structural genes despite their genomic diversity.

Authors:  Amir Ariff; Michael J Wise; Charlene M Kahler; Chin Yen Tay; Fanny Peters; Timothy T Perkins; Barbara J Chang
Journal:  BMC Genomics       Date:  2015-10-24       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.